← Back to Search

Treatment with Lavender for Intracranial Disease

Phase 1
Waitlist Available
Led By Richard A Rovin, MD
Research Sponsored by Aurora Health Care
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Any adult patient aged 18 and older undergoing awake cranial neurosurgery
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 8 hours
Awards & highlights

Study Summary

Awake craniotomy for tumor surgery allows for mapping of speech, motor and sensory function during tumor resection. Awake craniotomy is increasingly utilized as it has several advantages over a traditional general anesthetic technique. Though many patients tolerate awake cranial surgery well, recent studies found that roughly 30% of patients experience moderate to severe pain and anxiety, while 50% report moderate fear and 11% report severe fear. Therefore, alternative methods to mitigate pain, anxiety, and fear are needed. In this study, the investigators will employ lavender aromatherapy to reduce anxiety and improve the satisfaction with pain control.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of consented patients
Protocol completion
Secondary outcome measures
Analgesic and anxiolytic dosage
Patient Opinion of Pain Management (POPM) survey
Validation of Visual Analogue Scale for Anxiety (VAS-A)
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment with LavenderExperimental Treatment1 Intervention
Lavender (Lavandula angustifolia) aromatherapy will be administered at regular intervals using a nasal inhaler.

Find a Location

Who is running the clinical trial?

Aurora Health CareLead Sponsor
42 Previous Clinical Trials
15,992 Total Patients Enrolled
Richard A Rovin, MDPrincipal InvestigatorAurora Health Care

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Apr 2025